CREUTZFELDT-JAKOB DISEASE AFTER ADMINISTRATION OF HUMAN GROWTH HORMONE
- 2 August 1985
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 326 (8449), 244-246
- https://doi.org/10.1016/s0140-6736(85)90292-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- PREPARATION OF GROWTH HORMONE FREE FROM CONTAMINATION WITH UNCONVENTIONAL SLOW VIRUSESThe Lancet, 1985
- WITHDRAWAL OF HUMAN PITUITARY GROWTH HORMONEThe Lancet, 1985
- Evidence for case-to-case transmission of Creutzfeldt-Jakob diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1982
- Creutzfeldt-Jakob disease in an adolescentJournal of the Neurological Sciences, 1981
- Creutzfeldt‐Jakob disease in a 20‐year‐old womanNeurology, 1980
- LARGE-SCALE PREPARATION OF HIGHLY PURIFIED PYROGEN-FREE HUMAN GROWTH HORMONE FOR CLINICAL USEJournal of Endocrinology, 1979
- Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clusteringAnnals of Neurology, 1979
- Precautions in Medical Care of, and in Handling Materials from, Patients with Transmissible Virus Dementia (Creutzfeldt-Jakob Disease)New England Journal of Medicine, 1977
- DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERYThe Lancet, 1977
- Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the ChimpanzeeScience, 1968